0000000000758935

AUTHOR

E. Cillari

Persistence of antibodies to Leishmania after an acute attack of visceral Leishmaniasis

research product

Effect of maximal exercise on reticulocytes in athletes

research product

The role of cytokines and apoptosis in the protection against human visceral Leishmaniasis

research product

IL-15, as IFN-gamma, induces the killing of Leishmania infantum in PMA-activated macrophages increasing IL-12

research product

Prevalence of antibodies anti-bartonella henselae in western sicily: children, blood donors, and cats.

research product

Advances in leishmaniasis immunopathogenesis

research product

Production of VEGF and b-FGF in drainage fluid from patients undergoing incisional hernia repair

research product

Mevalonate pathway: role of bisphosphonates and statins.

research product

Apoptosi dei subsets linfocitari CD4+/ CCR5+, CD4+/ CCR3+ e dei monociti in pazienti con leishmaniasi viscerale acuta

research product

Immunology of human rickettsial diseases.

Among human rickettsial diseases caused by micro-organisms of the genus Rickettsia (Order Rickettsiales; Family Rickettsiaceae), transmitted to human hosts through arthropod vectors, Mediterranean Spotted Fever, or Boutonneuse Fever, and Rocky Mountain Spotted Fever are considered to be important infectious diseases due to continued prevalence in the developed world, and potentially fatal outcome in severe cases. Proliferation of rickettsiae, at the site of the tick bite, results in focal epidermal and dermal necrosis (tache noire). Rickettsiae then spread via lymphatic vessels to the regional lymph nodes, and, via the bloodstream, to skin, brain, lungs, heart, liver, spleen and kidneys. Th…

research product